Because this B cell trend was not observed in the Prod cohort, we hypothesize that the inflammatory-mediated genetic risk of LRRK2 variants may affect the chronic immune responses in defined PD, rather than the first presence of neuronal debris or alpha-synuclein. This evidence concerns the gene LRRK2 and Parkinson disease.